Chlamydia Screening Policy
Chlamydia Screening Policy
Chlamydia Screening Policy
Page 1 of 12
Table of Contents 1. Introduction...................................................................................................................2 2. Purpose of this Policy ...................................................................................................2 3. Scope ...........................................................................................................................2 4. Definitions / Glossary....................................................................................................2 5. Ownership and Responsibilities....................................................................................2 5.2. 5.3. 6.7. 6.10. 6.11. 6.17. 6.18. 6.19. 6.29. 6.30. 6.35. 6.38. 6.41. 6.42. Role of the Chlamydia screening steering Group ............................................2 Role of Individual Staff ........................................................................................3 Requesting screening .........................................................................................3 Screening venues ............................................................................................3 Reporting Procedures; how the patient is informed. ....................................4 Management of test negatives ........................................................................4 Management of test positives .........................................................................4 Treatment Standards .......................................................................................4 Partner notification ..........................................................................................5 The PN discussion ...........................................................................................5 Follow-up ..........................................................................................................5 Test of cure.......................................................................................................6 Confidentiality ..................................................................................................6 Child protection ...............................................................................................6
7. Dissemination and Implementation...............................................................................7 8. Monitoring compliance and effectiveness .....................................................................7 9. Updating and Review....................................................................................................7 10. Equality and Diversity................................................................................................7 Equality Impact Assessment ..........................................................................7 10.2.
Appendix 1. Governance Information ..................................................................................8 Appendix 2.Initial Equality Impact Assessment Screening Form .......................................10
1. Introduction
1.1. The National Chlamydia Screening Programme (NCSP) is a control and prevention programme targeted at the highest risk group for chlamydia infection in England, young people under 25 who are sexually active. 1.2. Chlamydia is the most common bacterial sexually transmitted infection (STI) in the UK; affecting both men and women. Most people with chlamydia have no symptoms, but left untreated, chlamydia, can lead, in women, to infertility, ectopic pregnancy and chronic pelvic pain. In men it may cause urethritis and epidydimitis. In both sexes it can cause arthritis. 1.3. The Cornwall Chlamydia screening office overseas the implementation of the NCSP in the resident 15 24 year old population of Cornwall. 1.4. Chlamydia is often asymptomatic so a large proportion of cases remain undiagnosed, but infection can be diagnosed easily (young people can do the test themselves), and treated effectively.
2.2. The NCSP aims to ensure that all sexually active men and women under 25 years of age are aware of chlamydia, its effects, and have access to services providing screening, prevention and treatment to reduce their risk of infection or onward transmission.
3. Scope
Applies to all those engaged with the Cornwall Chlamydia screening programme.
4. Definitions / Glossary
CSO - Chlamydia screening office NCSP National Chlamydia Screening programme CCSO Cornwall Chlamydia screening office
Page 2 of 12
6.5. The NCSP does not include those that cannot give consent, anyone unwilling to give any means of contact for the result, and under 16s not deemed Fraser competent. 6.6. Young people should be encouraged to be tested annually or whenever there is a change in sexual partner. Additional repeat testing may be required according to risk assessment by clinical staff.
Page 3 of 12
Remote testing testing kits can be requested by young people through websites, which can be posted to them
>90% of patient results to be notified within 10 days of the sample being provided.
6.18.
Three documented attempts to report positive results to the patent should be made.
Safe sex advice including details of local services The offer of a full STI screen including information on clinic locations and opening times
6.24. Young people testing positive and their partners should be encouraged to abstain from sex until all have been treated; this includes the period of treatment and the next seven days for all people. 6.25. Young women on the combined oral contraceptive pill need to be counselled about their choice of contraceptive method and its interaction with treatment. Providers may consider recommending and/or prescribing emergency contraception to women who may not have abstained from sex or used extra precautions while on antibiotics for a further seven days. 6.26. Individuals suspected of clinical treatment failure should be managed according to the BASHH guidelines. 6.27. Treatment should be free of charge. 6.28. Treatment must be administered by either medical practitioners or other clinical staff legally covered to work under patient group directions (PGDs).
6.35. Follow-up
6.36. Follow up is an important part in the management of chlamydia. The objectives include
Chlamydia Screening Policy
Page 5 of 12
Following up partner notification Reinforcing health education Ensuring compliance with treatment and abstinence from sexual intercourse until partner(s) has completed antibiotics (if treated with azithromycin waiting seven days). Re-treating non-compliant and/or re-exposed individuals.
6.37. The CSO will contact all positive patients two weeks after informing them of a result in order to monitor the above objectives.
6.41. Confidentiality
All staff involved with testing, providing results, treatment or PN must adhere to national and professional Guidelines concerning patient confidentiality: British Association for Sexual Health and HIV (2010) Standards for the management of sexually transmitted infections (STIs) Department of Health, Caldicott Committee (1997) Report on the Review of Patient Identifiable Information. Department of Health (2000) NHS Trusts and Primary Care Trusts (Sexually Transmitted Diseases) Directions 2000. Department of Health (2003) Confidentiality Code of Practice.
Page 6 of 12
The chlamydia screening lilie patient management database holds the patient information required and a formatted report template will be used to extract the monitoring information. Frequency Monitoring will be completed by financial quarter 30 days after the last day of the quarter. Reporting The report will be completed and a copy placed within the NHSLA arrangements evidence store. Acting on The CSO coordinator will undertake recommendations and recommendations complete them in an agreed timeframe. and Lead(s) Change in Required changes to practice will be identified and actioned within practice and an agreed and specific time frame. A lead member of the team will lessons to be be identified to take each change forward where appropriate. shared Lessons will be shared with all the relevant stakeholders.
Page 7 of 12
Suggested Keywords: Target Audience Executive Director responsible for Policy: Date revised: This document replaces (exact title of previous version): Approval route (names of committees)/consultation: Divisional Manager confirming approval processes Name and Post Title of additional signatories Signature of Executive Director giving approval Publication Location (refer to Policy on Policies Approvals and Ratification): Document Library Folder/Sub Folder Links to key external standards Related Documents:
Clinical / Sexual Health NHSLA Risk Management Standards. National Chlamydia screening programme core requirements.
Page 8 of 12
Training Need Identified? Version Control Table Date 1 Apr 12 Versio n No V1.0
No
Changes Made by (Name and Job Title) Matt Sharp, Chlamydia screening co-ordinator.
All or part of this document can be released under the Freedom of Information Act 2000 This document is to be retained for 10 years from the date of expiry. This document is only valid on the day of printing Controlled Document This document has been created following the Royal Cornwall Hospitals NHS Trust Policy on Document Production. It should not be altered in any way without the express permission of the author or their Line Manager.
Page 9 of 12
All sexually active men and women under 25 years of age No.
*Please see Glossary 7. The Impact Please complete the following table using ticks. You should refer to the EA guidance notes for areas of possible impact and also the Glossary if needed. Where you think that the policy could have a positive impact on any of the equality group(s) like promoting equality and equal opportunities or improving relations within equality groups, tick the Positive impact box. Where you think that the policy could have a negative impact on any of the equality group(s) i.e. it could disadvantage them, tick the Negative impact box. Page 10 of 12
Where you think that the policy has no impact on any of the equality group(s) listed below i.e. it has no effect currently on equality groups, tick the No impact box. Positive Impact Negative Impact No Impact Reasons for decision
Equality Group Age Disability Religion or belief Gender Transgender Pregnancy/ Maternity Race Sexual Orientation Marriage / Civil Partnership
You will need to continue to a full Equality Impact Assessment if the following have been highlighted: A negative impact and No consultation (this excludes any policies which have been identified as not requiring consultation). 8. If there is no evidence that the policy promotes equality, equal opportunities or improved relations - could it be adapted so that it does? How? Full statement of commitment to policy of equal opportunities is included in the policy
Please sign and date this form. Keep one copy and send a copy to Matron, Equality, Diversity and Human Rights, c/o Royal Cornwall Hospitals NHS Trust, Human Resources Department, Chyvean House, Penventinnie Lane, Truro, Cornwall, TR1 3LJ A summary of the results will be published on the Trusts web site.
Signed ___________Matt Sharp _______________ Date _____________ 1 Apr 12 ________________
Page 11 of 12